Search research articles
Contact Us
Filters
Showing results (1-10 of 58) with videos related to
Page
of 6
Sort By:
Expert Review of Anti-Infective Therapy
|
June 23, 2011
Lessons from maraviroc clinical trials
Paolo Troia-Cancio, David M Asmuth
Current Opinion in Infectious Diseases
|
April 18, 2014
Mucosal immunity in HIV infection: what can be done to restore gastrointestinal-associated lymphoid tissue function?
Michael D George, David M Asmuth
Expert Opinion on Investigational Drugs
|
December 16, 2015
Peginterferon α-2a for the treatment of HIV infection
David M Asmuth, Netanya S Utay, Richard B Pollard
Journal of Medical Virology
|
January 17, 2012
Quantitation of hepatitis C virus RNA in peripheral blood mononuclear cells in HCV-monoinfection and HIV/HCV-coinfection
Aarthi Chary, Mark A Winters, Robert Eisen, et al.
The Prostate
|
August 23, 2005
E2F1 expression in LNCaP prostate cancer cells deregulates androgen dependent growth, suppresses differentiation, and enhances apoptosis
Stephen J Libertini, Clifford G Tepper, Moraima Guadalupe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 21, 2004
Treatments for hepatitis B
David M Asmuth, Hien H Nguyen, Gregory P Melcher, et al.
Cancer Research
|
October 3, 2007
Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence
Stephen J Libertini, Clifford G Tepper, Veronica Rodriguez, et al.
Drug Development Research
|
June 10, 2021
Potential use of serum-derived bovine immunoglobulin/protein isolate for the management of COVID-19
Netanya S Utay, David M Asmuth, Shahin Gharakhanian, et al.
Journal of AIDS & Clinical Research
|
June 9, 2015
Differential Specificity of Interferon-alpha Inducible Gene Expression in Association with Human Immunodeficiency Virus and Hepatitis C Virus Levels and Declines <i>in vivo</i>
Antonios Katsounas, Astrid C Frank, Richard A Lempicki, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 17, 2009
CD4+ T-cell restoration after 48 weeks in the maraviroc treatment-experienced trials MOTIVATE 1 and 2
David M Asmuth, James Goodrich, David A Cooper, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 58) with videos related to
Sort By:
Page
of 6
Expert Review of Anti-Infective Therapy
|
June 23, 2011
Lessons from maraviroc clinical trials
Paolo Troia-Cancio, David M Asmuth
Current Opinion in Infectious Diseases
|
April 18, 2014
Mucosal immunity in HIV infection: what can be done to restore gastrointestinal-associated lymphoid tissue function?
Michael D George, David M Asmuth
Expert Opinion on Investigational Drugs
|
December 16, 2015
Peginterferon α-2a for the treatment of HIV infection
David M Asmuth, Netanya S Utay, Richard B Pollard
Journal of Medical Virology
|
January 17, 2012
Quantitation of hepatitis C virus RNA in peripheral blood mononuclear cells in HCV-monoinfection and HIV/HCV-coinfection
Aarthi Chary, Mark A Winters, Robert Eisen, et al.
The Prostate
|
August 23, 2005
E2F1 expression in LNCaP prostate cancer cells deregulates androgen dependent growth, suppresses differentiation, and enhances apoptosis
Stephen J Libertini, Clifford G Tepper, Moraima Guadalupe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 21, 2004
Treatments for hepatitis B
David M Asmuth, Hien H Nguyen, Gregory P Melcher, et al.
Cancer Research
|
October 3, 2007
Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence
Stephen J Libertini, Clifford G Tepper, Veronica Rodriguez, et al.
Drug Development Research
|
June 10, 2021
Potential use of serum-derived bovine immunoglobulin/protein isolate for the management of COVID-19
Netanya S Utay, David M Asmuth, Shahin Gharakhanian, et al.
Journal of AIDS & Clinical Research
|
June 9, 2015
Differential Specificity of Interferon-alpha Inducible Gene Expression in Association with Human Immunodeficiency Virus and Hepatitis C Virus Levels and Declines <i>in vivo</i>
Antonios Katsounas, Astrid C Frank, Richard A Lempicki, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 17, 2009
CD4+ T-cell restoration after 48 weeks in the maraviroc treatment-experienced trials MOTIVATE 1 and 2
David M Asmuth, James Goodrich, David A Cooper, et al.
Page
of 6